Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.220
-0.060 (-4.69%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Bone Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 5.33 | 3.33 | 3.03 | 7.54 | 6.68 | |
| Cash & Short-Term Investments | 5.33 | 3.33 | 3.03 | 7.54 | 6.68 | |
| Cash Growth | 60.42% | 9.87% | -59.85% | 12.93% | - | |
| Other Receivables | 0.01 | - | - | - | - | |
| Receivables | 0.01 | - | - | - | - | |
| Prepaid Expenses | 0.24 | 0.28 | 0.38 | 0.38 | - | |
| Other Current Assets | 0.21 | 0.26 | 0.33 | 0.58 | - | |
| Total Current Assets | 5.8 | 3.86 | 3.74 | 8.5 | 6.68 | |
| Accounts Payable | 0.42 | 0.37 | 0.36 | 0.1 | 0.1 | |
| Other Current Liabilities | 0 | 0 | 0.47 | 2.44 | - | |
| Total Current Liabilities | 0.42 | 0.38 | 0.83 | 2.55 | 0.1 | |
| Common Stock | 0 | 0 | 0 | 0 | 0.01 | |
| Additional Paid-In Capital | 93.51 | 88.5 | 83.81 | 77.91 | 77.04 | |
| Retained Earnings | -88.13 | -85.02 | -80.91 | -71.96 | -70.48 | |
| Total Liabilities & Equity | 5.8 | 3.86 | 3.74 | 8.5 | 6.68 | |
| Net Cash (Debt) | 5.33 | 3.33 | 3.03 | 7.54 | 6.68 | |
| Net Cash Growth | 60.42% | 9.87% | -59.85% | 12.93% | - | |
| Net Cash Per Share | 4.54 | 13.14 | 69.01 | - | - | |
| Filing Date Shares Outstanding | 1.8 | 0.55 | 0.09 | 0.01 | - | |
| Total Common Shares Outstanding | 1.8 | 0.49 | 0.09 | 0.01 | - | |
| Working Capital | 5.38 | 3.48 | 2.91 | 5.95 | 6.58 | |
| Book Value Per Share | 3.00 | 7.08 | 32.64 | 559.69 | - | |
| Tangible Book Value | 5.38 | 3.48 | 2.91 | 5.95 | 6.58 | |
| Tangible Book Value Per Share | 3.00 | 7.08 | 32.64 | 559.69 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.